Using the binary response status, which combines SD +PD (see the Methods section), we found no association to levels of sPD-L1 at baseline or on treatment in either CheckMate 009/RCC or CheckMate 038-P1/melanoma (online supplemental figure S2A–F). Here, SPDL1 is linked to renal cell carcinoma.